David Carlson (Trades, Portfolio) manages the $2.88 billion equity portfolio of the Elfun Trust, which is composed of 43 stocks. It sold shares of the following stocks during the second quarter of 2020.
S&P Global
The fund trimmed its position in S&P Global Inc. (SPGI, Financial) by 25.82%. The trade had an impact of -0.71% on the portfolio.
The company, which provides credit ratings, has a market cap of $84.41 billion and an enterprise value of $86.33 billion.
GuruFocus gives the company a profitability and growth rating of 9 out of 10. The return on equity of 998.07% and return on assets of 24.29% are outperforming 96% of companies in the capital markets industry. Its financial strength is rated 5 out of 10. The cash-debt ratio of 0.59 is below the industry median of 2.61.
The largest guru shareholder of the company is Spiros Segalas (Trades, Portfolio with 0.59% of outstanding shares, followed by Pioneer Investments (Trades, Portfolio) with 0.37% and Bill Nygren (Trades, Portfolio) with 0.33%.
PepsiCo
The fund reduced its PepsiCo Inc. (PEP, Financial) holding by 14.19%. The portfolio was impacted by -0.52%.
The food and beverage company has a market cap of $190.61 billion and an enterprise value of $226.56 billion.
GuruFocus gives the company a profitability and growth rating of 7 out of 10. The return on equity of 49.77% and return on assets of 8.44% are outperforming 75% of companies in the nonalcoholic beverages industry. Its financial strength is rated 5 out of 10. The cash-debt ratio of 0.2 is below the industry median of 0.52.
The largest guru shareholder of the company is Pioneer Investments with 0.47% of outstanding shares, followed by Yacktman Asset Management (Trades, Portfolio) with 0.24% and Diamond Hill Capital (Trades, Portfolio) with 0.17%.
Gilead Sciences
The fund exited its position in Gilead Sciences Inc. (GILD, Financial). The portfolio was impacted by -0.46%.
The company, which provides therapies to treat life-threatening infectious diseases, has a market cap of $87.22 billion and an enterprise value of $90.64 billion.
GuruFocus gives the company a profitability and growth rating of 8 out of 10. The return on equity of 22.6% and return on assets of 8.09% are outperforming 78% of companies in the drug manufacturers industry. Its financial strength is rated 5 out of 10. The cash-debt ratio of 0.86 is below the industry median of 0.87.
Some notable guru shareholders are Dodge & Cox with 1.20% of outstanding shares, Jim Simons (Trades, Portfolio)’ Renaissance Technologies with 1% and Pioneer Investments with 0.33%.
Booking
The fund closed its position in Booking Holdings Inc. (BKNG, Financial), impacting the portfolio by –0.45%.
The online travel agency has a market cap of $68.03 billion and an enterprise value of $69.83 billion.
GuruFocus gives the company a profitability and growth rating of 9 out of 10. The return on equity of 60.86% and return on assets of 12.26% are outperforming 96% of companies in the travel and leisure industry. Its financial strength is rated 6 out of 10. The cash-debt ratio of 0.8 is above the industry median of 0.42.
Some notable guru shareholders are Dodge & Cox with 4.18% of outstanding shares and Pioneer Investments with 0.59% and First Eagle Investment (Trades, Portfolio) with 0.57%.
CME Group
The investment fund curbed its holding in CME Group Inc. (CME, Financial) by 16.03%. The trade had an impact of -0.42% on the portfolio.
The company, which operates a global derivatives marketplace, has a market cap of $59.59 billion and an enterprise value of $62.23 billion.
GuruFocus gives the company a profitability and growth rating of 7 out of 10. The return on equity of 8.95% and return on assets of 2.47% are outperforming 70% of companies in the capital markets industry. Its financial strength is rated 4 out of 10. The cash-debt ratio of 0.43 is below the industry median of 2.61.
Another notable guru shareholder is Simons’ firm with 0.50% of outstanding shares, followed by Andreas Halvorsen (Trades, Portfolio) with 0.47%.
Alexion
The investment fund cut its Alexion Pharmaceuticals Inc. (ALXN, Financial) position by 19.23%. The trade had an impact of -0.38% on the portfolio.
The company, which develops drugs for rare, life-threatening medical conditions, has a market cap of $22.46 billion and an enterprise value of $22.22 billion.
GuruFocus gives the company a profitability and growth rating of 9 out of 10. The return on equity of 7.83% and return on assets of 5.17% are outperforming 95% of companies in the biotechnology industry. Its financial strength is rated 7 out of 10. The cash-debt ratio of 1.09 is below the industry median of 8.32.
The largest guru shareholder of the company is Simons’ firm with 1.70% of outstanding shares, followed by Pioneer Investments with 0.32% and Steven Cohen (Trades, Portfolio) with 0.29%.
ServiceNow
The investment fund cut its holding of ServiceNow Inc. (NOW, Financial) by 23.25%. The trade had an impact of -0.35% on the portfolio.
The software solutions provider has a market cap of $84.24 billion and an enterprise value of $83.09 billion.
GuruFocus gives the company a profitability and growth rating of 4 out of 10. The return on equity of 38.08% and return on assets of 12.96% are outperforming 89% of companies in the software industry. Its financial strength is rated 6 out of 10. The cash-debt ratio of 1.96 is below the industry median of 2.23.
The largest guru shareholder of the company is Frank Sands (Trades, Portfolio) with 2.04% of outstanding shares, followed by Steve Mandel (Trades, Portfolio) with 0.72%.
Disclosure: I do not own any stocks mentioned.
Read more here:
- The Vanguard Health Care Fund Cuts Eli Lilly, Merck & Co.​
- 5 Bargain Stocks With High Dividend Yields
- Insiders Roundup: Tetraphase Pharmaceuticals, Bank of America
Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.
